medigraphic.com
ISSN 1025-0255 (Electronic)

2015, Number 6

<< Back Next >>

AMC 2015; 19 (6)

Anesthetic management of patients with Charcot-Marie-Tooth’s disease

García ÁPJ, Cabreja ME, Estrada BY, Sanchez PY, Lavastida FH

Language: Spanish
References: 21
Page: 646-653
PDF size: 492.26 Kb.


ABSTRACT

Background: Charcot-Marie-Tooth's disease is a peripheral hereditary neuropathy that leads to muscular atrophy and loss of propioception in the affected areas. There is controversy regarding the ideal anesthetic technique for this disease.
Objective: to present the anesthetic management of a patient with this disease.
Clinical case: a female, twenty-eight-year-old patient that suffers from Charcot-Marie-Tooth’s disease who was operated on for a femoral fracture. Atrophy of both legs with equine foot became evident in the neurological exam. In the exam of superficial and deep sensitivity, distal hypoesthesia and apallesthesia became evident. The subarachnoid anesthetic technique was carried out. The patient presented autonomic disorders in the transoperative although no elements of dysautonomia were seen in the preoperative evaluation.
Conclusions: the advantages and disadvantages of every anesthetic technique should be analyzed in the anesthetic management of patients with Charcot-Marie-Tooth's disease, depending on the type of surgery. An evaluation of the cardiovascular system should be made looking for an atrial flutter and myocardiopathies. The increased sensitivity to some anesthetic drugs should be taken into consideration.


REFERENCES

  1. Molina Martín LA, Mustelier Bécquer R, Molina Martín JC, Hernández Silva Y, Gutiérrez Gil J. Actualidad genetica y clinica en las polineuropatias sensorimotoras hereditarias. Rev Cub Med vInterneta. 2013 citado 6 Jun 2015a;4(5):vaprox. 8 p.a. [ Disponible en: http://bvs.sld.cu/revistas/ rhab/vol4_num5/ actualidad_genetica_y_clinica.htm

  2. Soto Mesa D, Bermejo Alvarez M, Rubio Marauri P, García Menéndez M. Anesthetic considerations in Charcot - Marie - Tooth disease. Rev Esp Anestesiol Reanim Interneta. 2011 Apr vcitado 6 Jun 2015a;58[ aprox. 3 p.a. Disponible en: http://[:)4( www.ncbi.nlm.nih.gov/pubmed/21608285

  3. Takashima H. Clinical practice of hereditary motor neuropathy (HMN) and hereditary sensory and autonomic neuropathy (HSAN). [ Rinsho ShinkeigakuInterneta 2114 .[citado 6 Jun 2015a;54(12):vaprox. 3 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25672680

  4. Gálvez Cañellas J, Errando C, Martínez Torrente F, Mayor F, Zasadowski M, Villanueva Y, et al. Anaesthesia and orphan disease: difficult monitoring of neuromuscular blockade in a patient with severe Charcot - Marie - Tooth disease type I. [ Eur J AnaesthesiolInterneta 2113 .Dec [citado 6 Jun 2015a;30(12):vaprox. 4 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23698706

  5. Christian Miller M, Matías Yacsich M, Paula Valenzuela S, Jaime Jans B. Manejo anestésico en enfermedad de Charcot - Marie - Tooth: a propósito de un caso. Rev chil anest vInterneta. 2006Dic vcitado 6 Jun 2115[;35)3(:[aprox. 4 p.a. Disponible en: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/En línea/?IsisScript=iah/iah.xis&src=google&base=LILACS&lang=p&nextAction=lnk&ex

  6. Del Rio Vellosillo M, Garcia Medina J, Martin Gil PR. Anaesthetic management of a patient with Charcot - Marie - Tooth disease for staged [ diaphragmatic plication. Br J Anaesth Interneta 2114 .Feb vcitado 6 Jun 2015a;112)2(:[aprox. 4 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24431366

  7. Hughes R, Bevilacqua J, Neuropatía heredi-taria con predisposición a la parálisis por compresión. Presentación de casos clínicos y electrofisiológicos. Rev Hosp Clín Univ Chile vInterneta. 2009 vcitado 6 Jun 2015a;20(1):vaprox. 4 p.a. Disponible en: http://redhcuch.redclinica.cl/Portals/0/Users/014/14/14/Publicaciones/Revista/neuropatia_hereditaria.pdf

  8. Srivastava V, Pasha T, Knowles A, Boothman B, Paracha M, Kalkat M, et al. Dramatic improvement after bilateral diaphragmatic plication in Charcot-Marie-Tooth disease. Ann Thorac Surg vInterneta. 2014 Jun vcitado 6 Jun 2015a;97(6):vaprox. 3 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24882300

  9. Faldini C, Traina F, Nanni M, Mazzotti A, Calamelli C, Fabbri D, et al. Surgical treatment of cavus foot in Charcot-Marie-tooth disease: a review of twenty-four cases: AAOS exhibit selection. J Bone Joint Surg Am vInterneta. 2015 Mar 18 vcitado 6 Jun 2015a;97(6):vaprox. 30 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25788311?tool=MedlinePlus

  10. Echaniz Laguna A. The shifting paradigm of Charcot-Marie-Tooth disease. Rev Neurol (Paris) vInterneta. 2015 Apr vcitado 6 Jun 2015a;17(35):vaprox. 692 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25896909

  11. Manganelli F, Pisciotta C, Provitera V, Taioli F, Iodice R, Topa A, et al. Autonomic nervous system involvement in a new CMT2B family. J Peripher Nerv Syst vInterneta. 2012 Sep vcitado 6 Jun 2015a;17(3):vaprox. 5 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22971099

  12. Pasternak JJ, Lanier WL. Diseases of the Autonomic and Peripheral Nervous Systems. In: Hines RL, Marschall KE, editors. Stoelting's Anesthesia and Co-Existing Disease. Connecticut: Churchill Livingstone; 2008. p. 31.

  13. McSwain J, Doty J, Wilson S. Regional anesthesia in patients with pre-existing neurologic disease. Curr Opin Anaesthesiol vInterneta. 2014 Oct vcitado 6 Jun 2015a;27(5):vaprox. 5 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25051260

  14. Bösenberg A, Larkin K. Anaesthesia and Charcot-Marie-Tooth Disease. Southern African. J Anaest Anal vInterneta. 2014 Oct vcitado 6 Jun 2015a;12(4):vaprox. 4 p.a. Disponible en: http://www.tandfEn línea.com/doi/abs/10.1080/22201173.2006.10872453

  15. Isbister G, Burns J, Prior F, Ouvrier R. Safety of nitrous oxide administration in patients with Charcot-Marie-Tooth disease. J Neurol Sci vInterneta. 2008 May 15 vcitado 6 Jun 2015a;268(1-2):vaprox. 3 p.a. Disponible enhttp://www.ncbi.nlm.nih.gov/pubmed/18166200

  16. Antognini JF. Anaesthesia for charcot-marie-tooth disease: a review of 86 cases. Canadian J Anaesth. 1992 Apr vcitado 6 Jun 2015a;39(4):vaprox. 3 p.a. Disponible en: http://link.springer.com/article/10.1007%2FBF03009054

  17. Zhou J, Allen PD, Pessah IN, Naguib M. Neuromuscular Disorders and Malignant Hyperthermia. In: Miller RD, editor. Miller´Anesthesia. San Francisco, California: Elsevier; 2010. p. 1171-95.

  18. Naguib M,Samarkandi A. Response to atracurium and mivacurium in a patient with Charcot-Marie-Tooth disease. Canadian J Anaesth vInterneta. 1998 Jan vcitado 6 Jun 2015a;45(1):vaprox. 3 p.a. Disponible en: http://www.unboundmedicine.com/medline/citation/9466029/Response_to_atracurium_and_mivacurium_in_a_patient_with_Charcot_Marie_Tooth_disease_

  19. Pogson D, Telfer J, Wimbush S. Prolonged vecuronium neuromuscular blockade associated with Charcot Marie Tooth neuropathy. Br J Anaesth vInterneta. 2000 vcitado 6 Jun 2015a;85(6):vaprox. 4 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11732532

  20. Weimer L, Podwall D. Medication - induced exacerbation of neuropathy in Charcot Marie [ Tooth disease. J Neurol SciInterneta 2112 .Mar 15 [citado 6 Jun 2015a 1(242; - [:)2 aprox. 7 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16386273

  21. McSwain J, Doty J, Wilson S. Regional anesthesia in patients with pre-existing neurologic disease. Curr Opin Anaesthesiol vInterneta. 2014 Oct vcitado 6 Jun 2015a;27(5):vaprox. 5 p.a. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25051260




2020     |     www.medigraphic.com